Alteration in the Pharmacokinetics of Hemoglobin-Vesicles in a Rat Model of Chronic Liver Cirrhosis Is Associated with Kupffer Cell Phagocyte Activity-Reference-Cited by-同舟云学术

Alteration in the Pharmacokinetics of Hemoglobin-Vesicles in a Rat Model of Chronic Liver Cirrhosis Is Associated with Kupffer Cell Phagocyte Activity

Published:2011-02 Issue:2 Volume:100 Page:775-783
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Taguchi Kazuaki,Miyasato Mayumi,Watanabe Hiroshi,Sakai Hiromi,Tsuchida Eishun,Horinouchi Hirohisa,Kobayashi Koichi,Maruyama Toru,Otagiri Masaki

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference28 articles.

1. Fluid resuscitation with artificial oxygen carriers in hemorrhaged rats: Profiles of hemoglobin-vesicle degradation and hematopoiesis for 14days;Sakai;Shock,2009

2. Hemoglobin-vesicles suspended in recombinant human serum albumin for resuscitation from hemorrhagic shock in anesthetized rats;Sakai;Crit Care Med,2004

3. Purification of concentrated hemoglobin using organic solvent and heat treatment;Sakai;Protein Exp Purif,1993

4. Interaction of hemoglobin vesicles, a cellular-type artificial oxygen carrier, with human plasma: Effects on coagulation, kallikrein-kinin, and complement systems;Abe;Artif Cells Blood Substit Immobil Biotechnol,2006

5. Poly(ethylene glycol)-conjugation and deoxygenation enable long-term preservation of hemoglobin-vesicles as oxygen carriers in a liquid state;Sakai;Bioconjug Chem,2000

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liposome-Encapsulated Hemoglobin Vesicle Improves Persistent Anti-arrhythmogenesis through Improving Myocardial Electrical Remodeling and Modulating Cardiac Autonomic Activity in a Hemorrhagic Shock-Induced Rat Heart Model;Current Medical Science;2023-03-08

2. Changes in Disposition of Ezetimibe and Its Active Metabolites Induced by Impaired Hepatic Function: The Influence of Enzyme and Transporter Activities;Pharmaceutics;2022-12-08

3. Development of a bioactive gas delivery strategy based on biomimetic red blood cells for the treatment of intractable diseases;Drug Delivery System;2021-09-25

4. Pharmaceutical Technology Innovation Strategy Based on the Function of Blood Transport Proteins as DDS Carriers for the Treatment of Intractable Disorders and Cancer;Biological and Pharmaceutical Bulletin;2020-12-01

5. Safety Evaluation of Cellular-type Artificial Blood Based on Pharmacokinetic Analysis and Its Use in Medical Gas Delivery;YAKUGAKU ZASSHI;2018-11-01